Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Babesia duncani as a Model Organism to Study the Development, Virulence, and Drug Susceptibility of Intraerythrocytic Parasites In Vitro and In Vivo

2 May 2022

Abstract excerpt

Human babesiosis is a malaria-like illness caused by tick-borne intraerythrocytic Babesia parasites of the Apicomplexa phylum. Whereas several species of Babesia can cause severe disease in humans, the ability to propagate Babesia duncani both in vitro in human erythrocytes and in mice makes it a unique pathogen to study Babesia biology and pathogenesis. Here we report an optimized B. duncani in culture-in mouse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Malaria Research and Control
Share to Mosquito-borne diseases and control
Share to Vector-borne infectious diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35512141
DOI: 10.1093/infdis/jiac181

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Babesia duncani as a Model Organism to Study the Development, Virulence, and Drug Susceptibility of Intraerythrocytic Parasites In Vitro and In VivoPMID 35512141Read ↗

<i>Babesia duncani</i> as a model organism to study the development, virulence and drug susceptibility of intraerythrocytic parasites <i>in vitro</i> and <i>in vivo</i>Semantic proximity Read ↗

A Propidium Iodide-based <i>In Vitro</i> Screen of the “Bug Box” Against <i>Babesia duncani</i> Reveals Potent InhibitorsSemantic proximity Read ↗

Effective Therapy Targeting Cytochrome bc 1 Prevents Babesia Erythrocytic Development and Protects from Lethal InfectionSemantic proximity Read ↗

Decoding The Nuclear Genome of The Human Pathogen <i>Babesia duncani</i> Shed Light on its Virulence, Drug Susceptibility and Evolution among ApicomplexaSemantic proximity Read ↗

Babesia duncani in Culture and in Mouse (ICIM) Model for the Advancement of Babesia Biology, Pathogenesis and TherapySemantic proximity Read ↗

Establishment and Optimisation of Anti-Babesia microti Drug Efficacy Evaluation MethodSemantic proximity Read ↗

New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infectionsSemantic proximity Read ↗

Phenotypic profiling of Pathogen Box compounds MMV667494 and MMV028694 in bloodstream-form Trypanosoma brucei brucei.Semantic proximity Read ↗

Development of an Ectopic huLiver Model for <i>Plasmodium</i> Liver Stage InfectionSemantic proximity Read ↗

Advances in the macrolides and quinolones.Semantic proximity Read ↗

Evaluating Antimalarial Proteasome Inhibitors for Efficacy in Babesia Blood Stage CulturesSemantic proximity Read ↗

Promising antimalarial hits from phenotypic screens: a review of recently-described multi-stage actives and their modes of actionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.